Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Pharmacol Res. 2012 Nov 2;67(1):94–109. doi: 10.1016/j.phrs.2012.10.013

Fig. 9.

Fig. 9

Cisplatin decreases levels of (a) the endocannabinoid 2-AG in rat hind paw skin without altering levels of (b) AEA relative to saline treatment. Levels of (c, d) fatty-acid amides (OEA, PEA) and (e,f) other inflammatory mediators (PGE2,PGF) were not altered in rat hind paw skin relative to saline treatment. Data are expressed as mean ± s.e.m. (n = 6–8 per group). * P < 0.029 vs. Saline (t-test, two-tailed).